Kyle Melin to Male
This is a "connection" page, showing publications Kyle Melin has written about Male.
Connection Strength
0.286
-
Melin K, Zhang C, Zapata JP, Rivera YM, Fernandez K, Shacham E, Malav?-Rivera SM, Rodriguez-Diaz CE. Factors Associated with Intention to Receive Vaccination against COVID-19 in Puerto Rico: An Online Survey of Adults. Int J Environ Res Public Health. 2021 07 21; 18(15).
Score: 0.055
-
Melin K, Hilera-Botet CR, Vega-V?lez D, Salgado-Crespo VM, Santiago D, Hern?ndez-Agosto J, Mu?oz-Burgos A, Cajigas Z, Mart?nez-V?lez JJ, Rodr?guez-D?az CE. Readiness to provide pharmaceutical care to transgender patients: Perspectives from pharmacists and transgender individuals. J Am Pharm Assoc (2003). 2019 Sep - Oct; 59(5):651-659.
Score: 0.047
-
Jim?nez-Mangual BC, Cuevas-Acevedo DM, Quiles-Alves N, Rodr?guez-Nazario I, Melin KR. Description of Patients Medications Needs and the Community Pharmacist's Role in Puerto Rico Following a Natural Disaster. J Prim Care Community Health. 2019 Jan-Dec; 10:2150132719842701.
Score: 0.046
-
Melin K, Moon JY, Qi Q, Hernandez-Suarez DF, Duconge J, Hua S, Gonzalez S, Zeng D, Kaplan RC. Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort. Pharmacogenomics. 2019 01; 20(2):75-83.
Score: 0.046
-
Melin K, Conte-Schmidt N, Mart?nez-Arroyo K, Rosa-P?rez K, Soto-Avil?s AE, Hern?ndez-Mu?oz JJ. Knowledge and Perceptions of E-cigarettes and the Motivations for their Use: Talking to Smokers (E-cigarettes and/or Conventional Cigarettes) and Non-smokers in Puerto Rico. P R Health Sci J. 2018 09; 37(3):148-154.
Score: 0.045
-
Duconge J, Santiago E, Hernandez-Suarez DF, Moner? M, L?pez-Reyes A, Rosario M, Renta JY, Gonz?lez P, Ileana Fern?ndez-Morales L, Antonio V?lez-Figueroa L, Arce O, Mar?n-Maldonado F, Nu?ez H, Melin K, Scott SA, Rua?o G. Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach. Clin Transl Sci. 2021 11; 14(6):2254-2266.
Score: 0.014
-
Hernandez-Suarez DF, Tomassini-Fernandini JC, Cuevas A, Rosario-Berrios AN, Nu?ez-Medina HJ, Padilla-Arroyo D, Rivera N, Liriano J, Vega-Roman RK, Renta JY, Melin K, Duconge J. Clinical Relevant Polymorphisms Affecting Clopidogrel Pharmacokinetics and Pharmacodynamics: Insights from the Puerto Rico Newborn Screening Program. Int J Environ Res Public Health. 2018 05 30; 15(6).
Score: 0.011
-
Hernandez-Suarez DF, N??ez-Medina H, Scott SA, Lopez-Candales A, Wiley JM, Garcia MJ, Melin K, Nieves-Borrero K, Rodriguez-Ruiz C, Marshall L, Duconge J. Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel therapy. Drug Metab Pers Ther. 2018 03 28; 33(1):49-55.
Score: 0.011
-
Hernandez-Suarez DF, Scott SA, Tomey MI, Melin K, Lopez-Candales A, Buckley CE, Duconge J. Clinical determinants of clopidogrel responsiveness in a heterogeneous cohort of Puerto Rican Hispanics. Ther Adv Cardiovasc Dis. 2017 Sep; 11(9):235-241.
Score: 0.010